Adnan M.M. Mjalli,Bradley Alan Clark,Dharma Rao Polisetti,James C. Quada, JR.,Maria Carmen Valcarce Lopez,Robert Carl Andrews,Stephen Thomas Davis,Thomas Scott Yokum
申请号：
US14799222
公开号：
US20150313908A1
申请日:
2015.07.14
申请国别(地区):
US
年份:
2015
代理人:
摘要：
The present invention provides uses of a glucagon-like peptide 1 receptor agonist in combination with metformin. Uses include treating type 2 diabetes, lowering blood glucose, and improving the therapeutic effectiveness of metformin. The invention also provides pharmaceutical compositions that comprise a GLP1R agonist and metformin.
